Ocumension Therapeutics (HKG:1477)
Hong Kong · Delayed Price · Currency is HKD 4.770
-0.120 (-2.45%)
Jul 9, 2026, 4:08 PM HKT
Ocumension Therapeutics Market Cap
Ocumension Therapeutics has a market cap or net worth of 3.89 billion as of July 9, 2026. Its market cap has decreased by -53.69% in one year.
Market Cap
3.89B
Enterprise Value
3.65B
Revenue
895.09M
Ranking
n/a
PE Ratio
n/a
Stock Price
4.77
Market Cap Chart
Since July 10, 2020, Ocumension Therapeutics's market cap has decreased from 21.28B to 3.89B, a decrease of -81.73%. That is a compound annual growth rate of -24.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 9, 2026 | 3.89B | -35.54% |
| Dec 31, 2025 | 6.03B | 64.39% |
| Dec 31, 2024 | 3.67B | -20.44% |
| Dec 29, 2023 | 4.61B | -30.21% |
| Dec 30, 2022 | 6.61B | -43.35% |
| Dec 31, 2021 | 11.67B | -26.90% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jul 10, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| TransThera Sciences (Nanjing) | 4.36B |
| Jacobio Pharmaceuticals Group | 3.87B |
| Mirxes Holding Company | 3.66B |
| Guangzhou Innogen Pharmaceutical Group | 3.64B |
| Qyuns Therapeutics | 3.53B |
| Medtide | 3.20B |
| Jiangsu Recbio Technology | 3.19B |
| Shandong Boan Biotechnology | 3.09B |